The Ibis division of lsis Pharmaceuticals has been granted two new contracts from the Department of Homeland security to develop a microbial forensics application of its triangulation identification for genetic evaluation risks (TIGER) biosensor system. Microbial forensics is used in the investigation of crimes involving infectious agents, comparing the genetic "fingerprint" of an infectious agent to that of a potential source.
The awards, totaling $1.5 million, will also support further development of the Microbial Rosetta Stone (MRS) database, a key component of the TIGER system, to include additional genetic information on infectious agents. Additional government-funded TIGER applications in development include bioweapons defense, biological product screening, and epidemiological surveillance. Ibis has set goals to deploy biosensor systems to government partners this year.
Комментариев нет:
Отправить комментарий